06 / REG
Regulatory-Grade RWE
Real-world evidence built to withstand regulatory review.
Real-world evidence pipelines validated to FDA and EMA expectations, with the documentation, audit trails, and provenance needed to move from insight to submission.
[ Overview ]
What we do
for your team.
We operate the way regulators expect: 21 CFR Part 11 aligned infrastructure, pre-registered protocols, deterministic pipelines, and full analytic traceability from raw data to result.
Whether you're supporting a label expansion, a post-marketing commitment, or a hybrid trial, we deliver evidence that reviewers can reproduce.
BiopharmaRegulatory AffairsCROs
[ Capabilities ]
- 21 CFR Part 11 aligned data infrastructure
- Protocol-driven RWE study execution
- Bias assessment, sensitivity & subgroup analyses
- Regulatory dossier authoring and submission support
- Fit-for-purpose data quality assessments
[ Outcomes ]
- 01
Submission-grade evidence packages for FDA & EMA
- 02
Fully traceable analytics from raw data to final results
- 03
Reduced review cycles through pre-registered protocols